-
New Comprehensive Clinical Guidance on VTE Treatment
-
ACCP Guideline for DVT and PE Treatment: New Edition, 2016
The ACCP Chest Guidelines have been the main guide over the last more than 2 decades for evidence-based recommendations on best management of anticoagulants for various indications, including DVT and PE. The 10th edition of the chapter on DVT and PE management was published in Jan 2016 [ref 1]. Unfortunately, the guideline is not available for non-subscribers.
-
Scuba Diving While on an Anticoagulant
-
MTHFR and Homocysteine: Information Handout for Patients
Stephan Moll, MD writes… A plain language summary for patients and interested public about homocysteine and the MTHFR mutations and their relevance in respect to thrombosis was published today in the journal Circulation (link here). Reference: Moll S, Varga EA. Homocysteine and MTHFR Mutations. Circulation. 2015;132:e6-e.
-
Warfarin Interruption for Surgery: Bridging with LMWH Often Not Needed
-
Reversal Agent for Pradaxa: Important NEJM Publication Today
-
Thrombophilia – Information Handout for Patients
Stephan Moll, MD writes… An information article on various aspects of thrombophilia, written for patients and family members, was published today – available here – as a Vascular Disease Patient Information Page in the journal Vascular Medicine. It addresses (a) in which patient with venous thromboembolism to consider thrombophilia testing, (b) what tests might be appropriate to do, (c) how the test results…
-
ASH 2014 Highlights: Thrombosis and Anticoagulation
Stephan Moll, MD writes… The annual American Society of Hematology (ASH) meeting took place in Dec 2014 in San Francisco. A summary of the clinically relevant thrombosis and anticoagulation presentation and abstracts is presented here (Top 10 ASH Highlights). Disclosure: I have been a consultant to Portola, Daiichi, Janssen, and Boehringer-Ingelheim. Last updated: Jan…
